OpSCF

· Opsidio, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OpSCF, covering 2024-05-07 to 2024-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis [Phase 2]